Gilead enters subscription-based contract with Louisiana for hepatitis C drugs - https://t.co/OLgAcpLEY3 https://t.co/DZUWQ9AH1P
— IDRO (@IDROOhio) March 28, 2019
from Twitter https://twitter.com/IDROOhio
March 27, 2019 at 10:02PM
Thursday, March 28, 2019
Gilead enters subscription-based contract with Louisiana for hepatitis C drugs - https://t.co/OLgAcpLEY3 https://t.co/DZUWQ9AH1P
from Twitter https://twitter.com/IDROOhio
March 27, 2019 at 10:02PM
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment